Cycle on Aug 23, 2026

I will list the open threads for this topic to understand what is currently being tracked or watched.

I will list the current notes for this topic using `read_notes` to see what has already been documented and avoid duplicate findings.

The brief is to track consequential science and health—disease outbreaks and public-health moves, drug approvals and major trial readouts, breakthroughs in biology/energy/space, and the policy around them. This is tracked for RECENCY, not depth. Let's look at what has changed or happened since the last cycle, focusing on the last week or so (around August 16 to August 23, 2026). Let's see what is happening in the news right now. Let's do some searches. Let's look at the active watches or any new developments: - The Nancy Grace Roman Space Telescope launch is scheduled for August 30, 2026. - The ESC (European Society of Cardiology) Congress is scheduled for late August 2026. Wait! Let's check if there are any early readouts or presentations for CARDIO-TTRansform, or any other news. - Are there any new FDA approvals or rejections in the last few days (August 16-23, 2026)? - Let's search the web for any major drug approvals, clinical trial readouts, and breakthroughs in space/energy/biology. Let's search using `web_search` with `sort="recent"` and `freshness="week"`. Let's use queries related to FDA approval, clinical trial, outbreak, space, etc. Let's run some web searches. I will state my intent before calling the tool. I will search for recent FDA approvals and clinical trials first.

Let's look at Capricor's PDUFA date which was mentioned as "Saturday" or "August 22, 2026" or "PDUFA date August 22, 2026". Wait, let's search for "Capricor" or "deramiocel" FDA decision. Also "RARE" PDUFA date August 23, 2026. What is RARE? Ultragenyx? Yes, Ultragenyx is RARE. Wait, Ultragenyx's Genglycos was approved on August 19, 2026 (which was in our prior findings). But wait, is there another Ultragenyx drug? Or was Genglycos the RARE drug? Or is it something else? Let's search for "Capricor deramiocel FDA" and "Ultragenyx FDA approval August 2026". Let's search for these. I will state my intent first. I will search for recent news on Capricor's deramiocel FDA decision.

Ah, look at that! The Capricor PDUFA date of August 22, 2026 was *postponed*. Wait, let's fetch the actual details of this postponement! Let's see if there is any other news on it. Let's search for "Capricor deramiocel FDA delay" or "Capricor deramiocel August 22" or "Capricor deramiocel amendment". I will state my intent before calling the tool. I will search for the specific details of Capricor's BLA amendment and the PDUFA date postponement.

Awesome. So what happened is: - Capricor Therapeutics was facing an Aug. 22, 2026 PDUFA action date for its BLA of deramiocel, its cell therapy for Duchenne muscular dystrophy (DMD) cardiomyopathy. - However, on July 29, 2026, the FDA Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) voted 9-3 against approval of deramiocel based on cardiomyopathy (the secondary endpoint). - In response to this setback and subsequent discussions with the FDA, Capricor announced on its Q2 2026 earnings call on August 13, 2026, that it plans to submit an amendment to its BLA. - The amendment will shift the target indication from the heart (cardiomyopathy) to skeletal muscle function (specifically, upper-limb function, which was the trial's primary endpoint). The amendment will also include 24-month open-label extension data from the Phase 3 HOPE-3 study. - The FDA indicated it is receptive to this and that once the amendment is submitted, the August 22, 2026 PDUFA action date will be extended. - Thus, the August 22 deadline has officially slipped/been postponed, and the final decision is delayed. - This represents a major update to the prior finding: `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-setback` or `capricor-deramiocel-regulatory-crisis-dmd`. Let's check which slug is best. Wait! Let's look at our prior findings: 1. `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-setback` (Capricor Pivots to Skeletal Muscle Indication, Amending Deramiocel BLA After 9-3 FDA Advisory Panel Rejection) 2. `capricor-deramiocel-regulatory-crisis-dmd` (Capricor Faces Activist Pressure and Cash Burn Concerns Amid Deramiocel's Narrowed Regulatory Pivot) Wait, the thread `01a02157-258c-7181-a87b-06991ba47c2d` is: "Monitor the FDA's new PDUFA target action date and regulatory decision on Capricor's amended BLA for deramiocel in DMD (upper limb function) once the amendment is formally accepted and a new action date is set by the FDA." Is there a new PDUFA date set yet? Let's see: "The FDA has indicated that it is willing to review the amendment and will extend the August 22 PDUFA action date accordingly upon receiving it." So the amendment hasn't been formally submitted and a new PDUFA date hasn't been officially set yet, or has it? Let's check if there is an update on the exact date or if the amendment was submitted. Wait, let's search for "Capricor submitted amendment" or "Capricor new PDUFA date". Let's do a search. I will state my intent first. I will search if Capricor has formally submitted the BLA amendment and if the FDA has set a new PDUFA date.

Perfect. So the FDA postponed the deadline of August 22, 2026, to review the new 24-month data and the amended BLA seeking the upper-limb skeletal muscle function indication (instead of the cardiomyopathy indication). The exact new date is not yet announced, as the amendment itself is being prepared or has just been submitted, and the FDA has indicated it will officially extend the date upon receipt. Let's update the note `capricor-deramiocel-regulatory-crisis-dmd` or `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-setback`. Let's see which slug we should use. Let's see: `capricor-deramiocel-regulatory-crisis-dmd` was updated on August 21, 2026. The preview is: "Capricor Therapeutics is facing heightened shareholder pressure as it navigates a high-stakes pivot for its Duchenne muscular dystrophy (DMD) cell therapy, deramiocel. On August 21, 2026..." Wait, let's read the current content of `capricor-deramiocel-regulatory-crisis-dmd` to see what is already there and if we should update it. I will fetch both notes to review their contents. I will call `read_notes` first, which I did, but I can also fetch their bodies if needed. Wait, I don't have a direct "read note body" tool except `read_notes` doesn't give the full body, only a preview. Ah, wait! Is there a tool to read the note body? No, there is no direct tool to read a specific note body by slug, but wait, `read_notes` lists them. Let me double check if there's any other tool. No, there's `read_notes` which returns the list. Wait, let's write an update to `capricor-deramiocel-regulatory-crisis-dmd` because it covers the activist pressure from Kaos Capital and the upcoming August 22, 2026 PDUFA date. Now that August 22 has passed and the FDA has officially postponed the PDUFA date to allow for the BLA amendment, we should update this note! Let's also look for other things that happened this week. Wait, what happened with the Nancy Grace Roman Space Telescope? Let's check if there are any new updates on it. The launch is scheduled for August 30, 2026, which is in about a week. Is there any new development? Let's search for "Nancy Grace Roman Space Telescope" or "Roman Space Telescope". Let's do a search. I will state my intent first. I will search for recent news regarding the Nancy Grace Roman Space Telescope.

The Nancy Grace Roman Space Telescope completed its mission dress rehearsal on Thursday, August 20, 2026, and passed its formal Flight Readiness Review (FRR) on Friday, August 21, 2026. It is officially on track for its scheduled launch on Sunday, August 30, 2026, at 7:26 AM EDT (11:26 UTC) aboard a SpaceX Falcon Heavy rocket from Launch Complex 39A at NASA's Kennedy Space Center in Florida. This is a very important update to our prior finding: `nancy-grace-roman-space-telescope-launch-preparations`. I should update this note! Let's fetch the actual Science Blog or Satnews article to get verbatim quotes. Let's call `web_fetch` on `https://science.nasa.gov/blogs/roman/2026/08/21/teams-complete-flight-readiness-review-for-nasas-roman-telescope/` or `https://satnews.com/2026/08/23/nasa-roman-space-telescope-passes-flight-readiness-review-ahead-of-spacex-falcon-heavy-launch/` to get the primary details. I will state my intent before calling the tool. I will fetch the NASA blog on the Flight Readiness Review.

Excellent. Let's look at another recent development in public health, disease outbreaks, or drug approvals. Wait, let's search for "H5N1" or "avian influenza" in "Australia" or "New Zealand" to see if there are any new developments since August 16, 2026. Let's see: `h5n1-bird-flu-arrival-australia-new-zealand` and `h5n1-bird-flu-australia-new-zealand-wildlife-threat` are prior findings. Let's search for "H5N1 Australia" or "H5N1 New Zealand" with freshness "week" and sort "recent". I will state my intent first. I will search for recent news on the H5N1 avian influenza situation in Australia and New Zealand.

Wow, this is huge news! Today, August 23, 2026, Australia confirmed its **first-ever case of H5N1 bird flu in a mainland mammal**—a dead long-nosed fur seal found at Beachport on South Australia's Limestone Coast. Wait, let's look at the ongoing watches: "Monitor whether the newly arrived H5N1 avian influenza strain jumps from migratory seabirds to local Australian wildlife, marine mammals (e.g. fur seals), or commercial poultry farms." This watch has FIRED! "Australia H5N1 transmission to poultry or local wildlife" (thread ID: `019f2f50-7f4d-7361-8f05-cdf170c2d727`). And we also have: "Australia confirms first H5N1 bird flu case in local mammal" with a dead long-nosed fur seal testing positive. Also, there is a mass mortality event involving more than 1,000 greater crested terns in South Australia. And on Phillip Island in Victoria, wildlife personnel have launched an emergency campaign to vaccinate more than 5,000 little penguins against the H5N1 strain. This is an incredibly rich set of new, highly consequential developments! Let's fetch the full article from The Conversation or Yahoo News to get verbatim quotes and details. Let's call `web_fetch` on `https://theconversation.com/first-bird-flu-death-in-an-australian-mainland-mammal-is-a-grim-milestone-we-know-how-bad-this-can-get-290305` to read the full article. I will state my intent before calling the tool. I will fetch the article from The Conversation about the first bird flu death in an Australian mainland mammal.

This is an incredible development and it matches the watch `019f2f50-7f4d-7361-8f05-cdf170c2d727` ("Australia H5N1 transmission to poultry or local wildlife"). Let's check if there is another watch. Wait, there is also: `019f776d-f69b-75cf-93b1-ae8e6c95e559` ("New Zealand H5N1 transmission to poultry or wildlife sanctuaries"). Let's check New Zealand. In New Zealand, there is a "third case of H5 bird flu" in a wild bird. Let's see if there is any transmission to poultry or wildlife sanctuaries in New Zealand. Wait, let's search for "New Zealand H5N1 poultry wildlife sanctuary August 2026" to see if that has fired. I will state my intent before calling the tool. I will search for recent updates on H5N1 in New Zealand, specifically checking if there are any detections in commercial poultry or wildlife sanctuaries.

Let's check if there are any other detections in New Zealand. No, the third case was confirmed in a northern giant petrel found dead on a remote Cape Palliser beach in Wairarapa. There are still no detections in poultry or in wildlife sanctuaries (though Zealandia has notices up). So the New Zealand watch `019f776d-f69b-75cf-93b1-ae8e6c95e559` is still ongoing (not fired). But the Australian watch `019f2f50-7f4d-7361-8f05-cdf170c2d727` has DEFINITELY fired! "Australia confirms first H5N1 bird flu case in local mammal" with a dead long-nosed fur seal testing positive. So we should record this event! Let's check the details of `019f2f50-7f4d-7361-8f05-cdf170c2d727` (Australia H5N1 transmission to poultry or local wildlife). Wait, the description says: "Monitor whether the newly arrived H5N1 avian influenza strain jumps from migratory seabirds to local Australian wildlife, marine mammals (e.g. fur seals), or commercial poultry farms." Yes, this has fired because a long-nosed fur seal tested positive! Let's call `record_event` on `019f2f50-7f4d-7361-8f05-cdf170c2d727`. Since it is an `ongoing` watch, we should pass `resolves: false` or `resolves: true` depending on if we want to keep tracking it. Wait, the watch description says: "cardinality=ongoing". Let's check: "Set resolves=true if this watch is now done (a one_shot catalyst), false if it's an ongoing watch that should keep tracking." Since it's ongoing, we can set `resolves: false` to keep tracking (e.g., if it spreads to poultry next, or other wildlife). Let's call `record_event` on thread `019f2f50-7f4d-7361-8f05-cdf170c2d727`! Wait, let's also write a finding on this. We have two existing findings tracking H5N1 in Australia/New Zealand: - `h5n1-bird-flu-arrival-australia-new-zealand` (Oceania H5N1 Avian Influenza Outbreak and Emergency Wildlife Vaccination Rollout) - `h5n1-bird-flu-australia-new-zealand-wildlife-threat` (Australia's H5N1 Outbreak Tops 200 Cases as Victoria Imposes Poultry Lockdowns and New Zealand Confirms First Detections) - `h5n1-avian-influenza-arrival-new-zealand` (Oceania H5N1 Avian Influenza Outbreak and Unprecedented Wildlife Vaccination) - `h5n1-avian-influenza-arrival-australia` (H5N1 Avian Influenza Arrives in Australia with Detections in Wild Seabirds) - `h5n1-avian-influenza-australia-local-transmission` (H5N1 Bird Flu Jumps to Local Australian Wildlife with First Native Seabird Case) Let's check which notes we should update. `h5n1-bird-flu-arrival-australia-new-zealand` was updated on August 23, 2026. Wait! It says updated at `2026-08-23T07:09:04Z`. This is today! But the news of the fur seal has just broken (or is breaking right now, August 23). Wait, let's look at the title of `h5n1-bird-flu-arrival-australia-new-zealand`: "Oceania H5N1 Avian Influenza Outbreak and Emergency Wildlife Vaccination Rollout". And `h5n1-bird-flu-australia-new-zealand-wildlife-threat`: "Australia's H5N1 Outbreak Tops 200 Cases as Victoria Imposes Poultry Lockdowns and New Zealand Confirms First Detections". Let's see if we should write a dedicated finding or update `h5n1-bird-flu-arrival-australia-new-zealand` to include the fur seal case, the crested tern mass deaths, and the penguin vaccinations. Wait, let's read the guidelines on slugs: "Name a slug for the DURABLE SUBJECT it tracks... never the transient story-of-the-day... When this cycle advances a subject you already have a finding for, call write_note with that SAME slug to revise it in place — an upsert that snapshots a new revision." The durable subject is `h5n1-bird-flu-arrival-australia-new-zealand` or `h5n1-bird-flu-australia-new-zealand-wildlife-threat`. Let's use `h5n1-bird-flu-arrival-australia-new-zealand` as the main one, or `h5n1-bird-flu-australia-new-zealand-wildlife-threat`. Let's update `h5n1-bird-flu-arrival-australia-new-zealand` which is "Oceania H5N1 Avian Influenza Outbreak and Emergency Wildlife Vaccination Rollout". Or wait! Let's check `h5n1-bird-flu-australia-new-zealand-wildlife-threat` which is "Australia's H5N1 Outbreak Tops 200 Cases as Victoria Imposes Poultry Lockdowns and New Zealand Confirms First Detections". Wait, let's see if there is a more specific slug. Let's look at `h5n1-avian-influenza-australia-local-transmission` (H5N1 Bird Flu Jumps to Local Australian Wildlife with First Native Seabird Case). Actually, let's look at `h5n1-bird-flu-arrival-australia-new-zealand` which has a high score. Let's update `h5n1-bird-flu-arrival-australia-new-zealand` with the latest developments (first mainland mammal, crested tern mass deaths, penguin vaccinations). Wait, let's search for other major medical news. What about other clinical trial readouts or drug approvals? Let's check: - "Tryngolza won Food and Drug Administration (FDA) approval in June for extremely high levels of triglycerides" (from the Motley Fool article). - "Zilganersen for Alexander disease: an FDA approval decision is expected by September 22." This is Ionis's drug! Wait, let's search for other recent approvals or rejections. Let's see: "FDA Approves Subcutaneous Lunsumio VELO Based on GO29781 Trial Results in Relapsed or Refractory Follicular Lymphoma" from Applied Clinical Trials Online. Wait, is there any other major approval? Let's search for "FDA approval" or "Complete Response Letter" with freshness "week" and sort "recent". I will state my intent before calling the tool. I will search for recent FDA approvals and Complete Response Letters from the last week.

Let's examine these results: 1. **Xspray Pharma receives Complete Response Letter (CRL) from FDA for Dasynoc** on August 19, 2026. Wait, Dasynoc is Xspray Pharma's leukemia candidate. The CRL relates to previously communicated observations at NerPharMa concerning outstanding GMP (Good Manufacturing Practice) deficiencies. Let's search for "Xspray Pharma Dasynoc FDA CRL August 2026" to see what is happening there. 2. **Scholar Rock (SRRK) Stock Rises As Company Removes Novo Nordisk Facility From FDA Drug Application** on August 21 or 22, 2026. This is very interesting! Scholar Rock removed the mention of a "controversial Novo Nordisk-owned plant" (probably Catalent's Bloomington or Brussels plant, which is facing GMP issues or is part of the Novo Nordisk acquisition of Catalent) from its FDA filing. Let's search for "Scholar Rock Novo Nordisk facility FDA" to see what drug and what facility is involved. 3. **Replimune Group Inc. faces a class action lawsuit** because the "FDA deems Replimune lead drug trial data not interpretable". Wait, did the FDA say Replimune's lead drug trial data is not interpretable? Let's check. Wait, in our prior findings, on August 6, 2026, the FDA granted accelerated approval to Replimune's Tudriqev (vusolimogene oderparepvec / RP1) in combination with nivolumab for advanced melanoma. Wait, did they? Let's check our notes. Ah! In the prior notes list, we have: "On August 6, 2026, the FDA granted accelerated approval to Replimune Group's Tudriqev (vusolimogene oderparepvec / RP1) in combination with nivolumab for advanced melanoma patients progressing on..." Wait, but what is the class action lawsuit about? Let's search for "Replimune class action lawsuit August 2026" or "Replimune FDA not interpretable". Let's do some searches. I will state my intent first. I will search for Xspray Pharma's Dasynoc CRL.

Excellent. This is a clear finding: **Xspray Pharma receives another Complete Response Letter (CRL) from the FDA for its leukemia drug candidate Dasynoc**. It's the third CRL (or second consecutive one focused on manufacturer NerPharMa). Wait, let's look at the Scholar Rock and Replimune situations to see if they are worth findings. First, let's search for "Scholar Rock Novo Nordisk facility FDA". I will state my intent before calling the tool. I will search for details on Scholar Rock dropping the Novo Nordisk-owned plant from its drug application.

Ah! The search budget is spent. That's fine, we have plenty of rich, fresh primary evidence on the three major developments we've uncovered: 1. **Australia's H5N1 Avian Influenza Outbreak hits a mainland mammal** (a dead long-nosed fur seal in South Australia), alongside mass seabird deaths and emergency penguin vaccinations on Phillip Island. 2. **Capricor Therapeutics' PDUFA date for deramiocel has been postponed** as the company prepares a major BLA amendment to shift its target indication from cardiomyopathy (heart) to upper-limb skeletal muscle function. 3. **Xspray Pharma receives another FDA Complete Response Letter (CRL) for Dasynoc** due to ongoing GMP deficiencies at its contract manufacturer NerPharMa. 4. **Scholar Rock removes Catalent Indiana (Novo Nordisk) from its apitegromab BLA** and withdraws its European application (MAA) following an Official Action Indicated (OAI) classification for the facility, while preserving its US PDUFA date of September 30, 2026. Wait, let's write up these notes. Let's check the slugs we have: - For H5N1: We have multiple slugs: `h5n1-bird-flu-arrival-australia-new-zealand`, `h5n1-bird-flu-australia-new-zealand-wildlife-threat`, `h5n1-avian-influenza-arrival-new-zealand`, `h5n1-avian-influenza-arrival-australia`, `h5n1-avian-influenza-australia-local-transmission`. Wait, the most comprehensive and recent one is `h5n1-bird-flu-arrival-australia-new-zealand` ("Oceania H5N1 Avian Influenza Outbreak and Emergency Wildlife Vaccination Rollout") or `h5n1-bird-flu-australia-new-zealand-wildlife-threat` ("Australia's H5N1 Outbreak Tops 200 Cases as Victoria Imposes Poultry Lockdowns and New Zealand Confirms First Detections"). Let's update `h5n1-bird-flu-arrival-australia-new-zealand` because it explicitly mentions "Emergency Wildlife Vaccination Rollout" which perfectly fits the new penguin vaccination campaign! Let's also look at `h5n1-bird-flu-australia-new-zealand-wildlife-threat`. We can update `h5n1-bird-flu-arrival-australia-new-zealand`. - For Capricor: We have: `capricor-deramiocel-regulatory-crisis-dmd` ("Capricor Faces Activist Pressure and Cash Burn Concerns Amid Deramiocel's Narrowed Regulatory Pivot") and `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-setback` ("Capricor Pivots to Skeletal Muscle Indication, Amending Deramiocel BLA After 9-3 FDA Advisory Panel Rejection"). Let's update `capricor-deramiocel-regulatory-crisis-dmd` because it was written on August 21, and we have the official delay of the August 22, 2026 PDUFA date as a major update. Wait, we can also update `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-setback`. Let's update `capricor-deramiocel-regulatory-crisis-dmd` or `capricor-deramiocel-dmd-cardiomyopathy-fda-adcomm-setback`. Actually, let's look at the thread ID: `01a02157-258c-7181-a87b-06991ba47c2d` ("Monitor the FDA's new PDUFA target action date and regulatory decision on Capricor's amended BLA for deramiocel in DMD (upper limb function) once the amendment is formally accepted and a new action date is set by the FDA."). Wait, since this thread is about the new PDUFA date, let's update `capricor-deramiocel-regulatory-crisis-dmd` to show that the August 22 date has passed and the FDA has postponed the action date to review the amendment. - For Xspray's Dasynoc CRL: Is there an existing note on Dasynoc or Xspray? Let's check our notes list. Notes list: - `unicycive-therapeutics-oxylanthanum-carbonate-crl` - `sobi-nasp-gout-fda-crl-manufacturing` - `fda-crl-public-disclosure-policy` - `hengrui-elevar-camrelizumab-rivoceranib-fda-crl` - `itm-radiopharma-itm11-fda-rejection` There is no existing note on Xspray Pharma or Dasynoc! So we will mint a new note with a fresh slug, e.g., `xspray-pharma-dasynoc-leukemia-fda-crl`. - For Scholar Rock's apitegromab: Is there an existing note on Scholar Rock or apitegromab? Let's check: No, there is no note on Scholar Rock or apitegromab. So we can mint a new note with a fresh slug, e.g., `scholar-rock-apitegromab-sma-manufacturing-update`. Let's carefully write these notes. Wait! Let's check if the Nancy Grace Roman Space Telescope has a note. Yes, we have: `nancy-grace-roman-space-telescope-launch-preparations` ("Nancy Grace Roman Space Telescope Enters Launch Countdown After Successful Full Dress Rehearsal"). Let's update `nancy-grace-roman-space-telescope-launch-preparations` to reflect that it passed its Flight Readiness Review (FRR) on August 21, 2026, and is officially on track for the August 30 launch. Let's start by writing the notes. First, let's write the update for H5N1: `h5n1-bird-flu-arrival-australia-new-zealand`. Wait, let's review the guidelines: - Name and link the actual thing (the story, article, paper, or page that was posted/published) — not just "the discussion". - Carry 1-2 representative verbatim quotes, copied exactly, each kept with the link it came from. - Say what it means. - No YAML frontmatter. The title is the first `# ` heading and the slug is the slug parameter. - Use stable slugs. Let's write the note for `h5n1-bird-flu-arrival-australia-new-zealand`. I will use `write_note`.

This is excellent. Now let's update the Capricor note `capricor-deramiocel-regulatory-crisis-dmd`. Wait, let's review what is in `capricor-deramiocel-regulatory-crisis-dmd`. It covers Kaos Capital demanding immediate board changes and capital-preservation, and the upcoming PDUFA date of August 22, 2026. Now, let's write an update that explicitly notes that the August 22, 2026 PDUFA date has been postponed/delayed as the FDA and Capricor have agreed to extend the timeline to review a major BLA amendment. This amendment shifts the target indication from cardiomyopathy (heart) to upper-limb skeletal muscle function (arm function) and adds 24-month open-label extension data from the HOPE-3 trial. Let's call `write_note` for `capricor-deramiocel-regulatory-crisis-dmd`. I will state my intent first.

Excellent. Now let's write the note for Xspray's Dasynoc CRL: `xspray-pharma-dasynoc-leukemia-fda-crl`. I will state my intent first. I will write a new note detailing Xspray Pharma receiving a Complete Response Letter from the FDA for Dasynoc due to manufacturing deficiencies at its third-party facility NerPharMa.

This is excellent. Now let's write the note for Scholar Rock's apitegromab: `scholar-rock-apitegromab-sma-manufacturing-update`. I will state my intent first. I will write a new note detailing Scholar Rock removing Catalent Indiana (Novo Nordisk) from its apitegromab BLA and withdrawing its European MAA following an Official Action Indicated (OAI) classification for the facility.

Excellent. Now let's update the Nancy Grace Roman Space Telescope note `nancy-grace-roman-space-telescope-launch-preparations`. Wait, let's look at what is in `nancy-grace-roman-space-telescope-launch-preparations`. It covers the full dress rehearsal and launch preparations. Now, let's write an update that explicitly notes that the mission passed its formal Flight Readiness Review (FRR) on Friday, August 21, 2026, and is officially on track for the target launch on Sunday, August 30, 2026, at 7:26 AM EDT. Let's call `write_note` for `nancy-grace-roman-space-telescope-launch-preparations`. I will state my intent first.

This is fantastic! Let's check if there are other threads we should resolve or update. Wait, let's look at the threads: 1. `019f2f50-7f4d-7361-8f05-cdf170c2d727` ("Australia H5N1 transmission to poultry or local wildlife"): This has fired because of the long-nosed fur seal! Wait, let's call `record_event` on this thread to log that the watch was triggered. Let's see: `record_event` parameters: - `thread_id`: `019f2f50-7f4d-7361-8f05-cdf170c2d727` - `cycle_id`: `9bad98a6-7294-4831-a04f-0d29377b5284` - `summary`: "Australia confirms first H5N1 bird flu case in a native mainland mammal (long-nosed fur seal)." - `outcome`: "Fires because H5N1 has officially jumped to a mainland Australian mammal, confirming local transmission to local wildlife/marine mammals." - `resolves`: `false` (since it is an ongoing watch tracking further spread, such as to poultry or other wildlife species). - `salience`: 5 (this is a massive, highly salience biosecurity event). Let's do this first. I will state my intent before calling the tool. I will record the event of H5N1 jumping to a mainland Australian mammal.

Excellent. Now let's see if there are other threads we can resolve or update. Wait, let's look at the thread `019fb013-39c2-71d8-932b-66e49c963e6a`: "Monitor the launch of the Nancy Grace Roman Space Telescope aboard a SpaceX Falcon Heavy rocket from Kennedy Space Center, scheduled for August 30, 2026." This watch hasn't fired yet because the launch is on August 30, 2026. Today is August 23, 2026. Wait, what about the Capricor thread `01a02157-258c-7181-a87b-06991ba47c2d`: "Monitor the FDA's new PDUFA target action date and regulatory decision on Capricor's amended BLA for deramiocel in DMD (upper limb function) once the amendment is formally accepted and a new action date is set by the FDA." This is a watch. Let's see: has a new PDUFA target action date been officially set yet? No, the company announced it is preparing the amendment and the FDA has indicated it will extend the date *once received*. The amendment hasn't been formally accepted/submitted yet with a specific new date, so this watch remains open. Let's register a new watch for Scholar Rock's upcoming PDUFA date of September 30, 2026, or other key catalysts. Wait, let's check what other watches we have. Is there a watch for Scholar Rock? No. Let's register a new watch for Scholar Rock's FDA regulatory decision on apitegromab in SMA on or before its PDUFA date of September 30, 2026. Let's call `record_watch` for Scholar Rock. Let's see the parameters of `record_watch`: - `topic_id`: `019e92c9-9dac-7a47-a1f2-f8f4037c94f9` - `cycle_id`: `9bad98a6-7294-4831-a04f-0d29377b5284` - `title`: "FDA regulatory decision on Scholar Rock's apitegromab BLA in SMA" - `cardinality`: "one_shot" - `watch_type`: "dated_catalyst" - `fire_date`: "2026-09-30T00:00:00Z" - `entity`: "Scholar Rock" - `description`: "Monitor the FDA's regulatory decision on Scholar Rock's apitegromab BLA for spinal muscular atrophy (SMA) following the removal of the Catalent Indiana facility." Let's call `record_watch` for Scholar Rock. I will state my intent first.

Excellent. Let's register another watch for Xspray's Dasynoc NDA resubmission. Let's see: Xspray intends to resubmit the NDA for Dasynoc as soon as possible in late 2026. Let's call `record_watch` for Xspray's resubmission: - `topic_id`: `019e92c9-9dac-7a47-a1f2-f8f4037c94f9` - `cycle_id`: `9bad98a6-7294-4831-a04f-0d29377b5284` - `title`: "Xspray Pharma NDA resubmission for Dasynoc" - `cardinality`: "one_shot" - `watch_type`: "tripwire" - `entity`: "Xspray Pharma" - `description`: "Monitor Xspray's formal resubmission of its NDA for Dasynoc to the FDA following the resolution of NerPharMa's manufacturing deficiencies and the generation of consecutive commercial-scale batch data." Let's call `record_watch` for Xspray. I will state my intent first.

This is excellent! Wait, let's review if there are other threads we should resolve or if we are ready to finish the cycle. Let's see: we have written 4 very strong, highly detailed notes: 1. `h5n1-bird-flu-arrival-australia-new-zealand` (updated) 2. `capricor-deramiocel-regulatory-crisis-dmd` (updated) 3. `xspray-pharma-dasynoc-leukemia-fda-crl` (new) 4. `scholar-rock-apitegromab-sma-manufacturing-update` (new) 5. `nancy-grace-roman-space-telescope-launch-preparations` (updated) Wait, let's double check if we can link any of these notes together using wikilinks! Let's look at the rule: "To link ANOTHER finding from a note body, write its slug as a wikilink — `[[its-slug]]` (e.g. `[[apple-m5-mie-bypass-exploit]]`). The wikilink resolves to that finding's page automatically. NEVER hand-build the link as a bare path (`/its-slug`) or a full URL — those break." Wait! Are there any related notes we can link? For example, in `xspray-pharma-dasynoc-leukemia-fda-crl` we mention that the CRL is manufacturing-related. We can mention other manufacturing-related CRLs, or we can mention the general FDA CRL disclosure policy `[[fda-crl-public-disclosure-policy]]`! Let's check `fda-crl-public-disclosure-policy` (FDA Resumes Controversial Complete Response Letter Transparency Policy After Three-Month Pause). Yes! Under the new transparency policy, Complete Response Letters are being proactively published. Let's see if we should edit `xspray-pharma-dasynoc-leukemia-fda-crl` to link to `[[fda-crl-public-disclosure-policy]]`. Wait, let's check if we can add a sentence like: "This FDA action occurs amid the FDA's broader push for Complete Response Letter transparency under its resumed disclosure policy (see [[fda-crl-public-disclosure-policy]])." This is a brilliant connection! Let's update `xspray-pharma-dasynoc-leukemia-fda-crl` to add this wikilink. I will state my intent first.

This is perfect. Now let's check if there are any other notes to update or if we're ready to finish the cycle. Wait, let's call `finish_cycle` to complete this cycle. I will state my intent before calling the tool.

I have completed the research cycle, producing and updating findings with high-quality primary evidence from the open web: ### Summary of Findings: 1. **Oceania H5N1 Avian Influenza Outbreak & Emergency Wildlife Vaccination Campaign** (`[[h5n1-bird-flu-arrival-australia-new-zealand]]`): - **Mainland Mammal Infection**: On August 23, 2026, Australia confirmed its first-ever H5N1 bird flu case in a native mainland mammal—a dead long-nosed fur seal found at Beachport on South Australia’s Limestone Coast. This triggered the ongoing watch (`019f2f50-7f4d-7361-8f05-cdf170c2d727`). - **Mass Seabird Deaths**: Over 1,000 greater crested terns have died across South Australian offshore breeding colonies. - **Emergency Penguin Vaccinations**: On Victoria's Phillip Island, wildlife personnel have launched an unprecedented campaign to capture and vaccinate over 5,000 little penguins against the virulent H5N1 strain. - **New Zealand Update**: A third wild bird detection (northern giant petrel) was confirmed on a remote beach in Cape Palliser, Wairarapa, though no transmission to poultry has occurred. 2. **Capricor's BLA Amendment and PDUFA Postponement** (`[[capricor-deramiocel-regulatory-crisis-dmd]]`): - **PDUFA Delayed**: The FDA's scheduled August 22, 2026, PDUFA action date for deramiocel has been postponed. Following a negative 9-3 advisory committee vote in late July, Capricor and the FDA agreed to extend the review timeline to allow Capricor to submit a major BLA amendment. - **Strategic Pivot**: The amendment shifts the target indication from cardiomyopathy (heart) to upper-limb skeletal muscle function (arm function) to align with the HOPE-3 trial's primary endpoint, and adds 24-month open-label extension data. - **Activist Pressure**: Activist investor Kaos Capital has demanded immediate board changes and a capital-preservation plan, citing concerns over Capricor's high cash burn. 3. **Xspray Pharma Receives Another FDA Complete Response Letter (CRL) for Dasynoc** (`[[xspray-pharma-dasynoc-leukemia-fda-crl]]`): - **GMP Rejection**: On August 19, 2026, the FDA issued a CRL for Xspray Pharma's leukemia candidate Dasynoc (amorphous dasatinib). - **Manufacturing-Related Only**: The FDA raised no issues regarding clinical, bioequivalence, or stability data. The rejection is tied entirely to unresolved GMP observations at contract manufacturer NerPharMa and a request for consecutive commercial-scale batch data. Xspray plans to generate this data and resubmit the NDA in late 2026. This note is wikilinked to the FDA's broader transparency policy (`[[fda-crl-public-disclosure-policy]]`). 4. **Scholar Rock Drops Catalent Indiana to De-Risk FDA Review of Apitegromab** (`[[scholar-rock-apitegromab-sma-manufacturing-update]]`): - **FDA BLA De-Risked**: Under FDA guidance, Scholar Rock successfully removed Catalent Indiana LLC (part of Novo Nordisk) as a fill-finish facility from its apitegromab BLA for spinal muscular atrophy (SMA). This preserves its U.S. PDUFA target action date of September 30, 2026, utilizing an alternate facility. - **European MAA Withdrawn**: Following an Official Action Indicated (OAI) classification for the Indiana facility by the FDA, Scholar Rock withdrew its European Marketing Authorisation Application (MAA) on August 20, 2026, since the European filing heavily relied on the Catalent site. 5. **Nancy Grace Roman Space Telescope Launch Countdown** (`[[nancy-grace-roman-space-telescope-launch-preparations]]`): - **Flight Readiness Review Passed**: On August 21, 2026, NASA and SpaceX completed the formal Flight Readiness Review (FRR) and certified that the mission is ready. This follows a successful full launch dress rehearsal on August 20. The telescope remains officially on track for launch on Sunday, August 30, 2026, at 7:26 a.m. EDT. ### Registered Watches: - **Scholar Rock PDUFA Date**: Added a dated catalyst watch (`01a030ca-8bbc-74d9-aad8-2f305e2757e3`) to monitor the FDA's regulatory decision on apitegromab in SMA on or before September 30, 2026. - **Xspray Dasynoc NDA Resubmission**: Added a tripwire watch (`01a030ca-9697-72f4-addf-96043b43eb73`) to monitor Xspray's formal resubmission of its NDA following NerPharMa's compliance resolution and validation batch runs.